What organization, societies or groups are there to support patient with this type of cancer?
National Cancer Society Malaysia
How to help the patients?
- By providing chemotherapy and radiotherapy / brachytherapy treatment under one roof, our patients are able to undergo treatment comfortably and do not have to travel around.
- Our rates are minimal and highly subsidized – this means more people are able to receive treatment, increasing the chances of cancer survival.
- We have little or no waiting list policy, which means patients can begin treatment usually on the same day after consulting our oncologists and completing the necessary investigations. Those who need a more complicated treatment method will start their treatment on the next day.
- We have 2 linear accelerators which means the possibility of machine breakdowns that causes treatment delays or cancellations are reduced.
- Our warm and friendly staff will make you feel at ease. Language is not a barrier as our staff are multilingual. Patients who are referred to this centre come from all over the world such as Taiwan, Indonesia, Thailand, Middle East and Australia.
Their services
1. Radiotherapy
2. High Dose Brachytherapy
3. Chemotherapy
4. Hormone therapy
Nilai Centre Institute
NCI Cancer Hospital (formerly known as Nilai Cancer Institute) is the pioneer private specialist center in Malaysia. We focus equally on two core activities: cancer treatment and clinical research.
Their services
Chemotherapy:
- Systematic and intravenous chemotherapy
- Immunotherapy
- Hormonal therapy and endocrine therapy
- Biological therapy
- Transarterial chemoembolization
Oncology:
At NCI, our oncologists are at the core of our comprehensive cancer care program. In addition to providing patient care, they participate in clinical trials and cancer related research that can help advance the quest for a cure.
City of Hope Lymphoma Specialized Program of Research Excellence (SPORE) in Singapore.
- Develop anti-CD30 based radio immunotherapy for both Hodgkin’s and CD30+ non-Hodgkin’s Lymphoma.
- Study a population of patients with Hodgkin’s and non-Hodgkin’s Lymphoma to investigate the cellular and molecular factors that are predictive for development of myelodysplasia, and to determine the molecular sequence of events that lead to myelodysplasia.
The Leukemia & Lymphoma Society (LLS), founded in 1949, is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services.
LLS's mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and to improve the quality of life of patients and their families.
LLS created the Information Resource Center (IRC) to provide blood cancer patients, their families and health professionals accurate, current disease information and support. IRC information specialists are social workers, nurses and health educators.
The Leukemia & Lymphoma Society (LLS) offers many ways to help you cope, from live telephone support to family support groups to online chats and more.
We also offer free informational publications and education programs, such as:
- disease and treatment guides for Hodgkin's lymphoma and NHL
- the Lymphoma Education Series featuring the latest information about each disease type and treatment options
- LymphomaLinks, a monthly eNewsletter with the latest news, research updates, clinical trials and events sponsored by LLS
- eNewsline, a monthly eNewsletter with the latest information about blood cancer research and treatment, LLS events, news and featured LLS programs and comments from individuals coping with blood cancer.
